Surgical versus medical castration in the Bahamas: a male macho paradox

Parkin DM, Bray F, Ferlay J: Global Cancer Statistics, 2002. CA Cancer J Clin. 2005, 55: 74-108. 10.3322/canjclin.55.2.74.

American Cancer Society: Cancer Facts and Figures 2006. 2006, Atlanta, Ga: American Cancer Society

Quinn M, Babb P: Patterns and trends in Prostate cancer incidence, survival, prevalence and mortality. Part 1; international Comparisons. BJU International. 2002, 90: 162-173. 10.1046/j.1464-410X.2002.2822.x.

Hsieh K, Albertsen PC: Populations at high risk for Prostate cancer. Urol Clin North Am. 2003, 30: 669-676. 10.1016/S0094-0143(03)00058-2.

Glover FE, Coffey DS, Douglas LL: The Epidemiology of Prostate Cancer in Jamaica. J Urol. 1998, 159 (6): 1984-1986. 10.1097/00005392-199806000-00063.

Bunker CH, Patrick AL, Kinety BR: High Prevalence of Screening-detected Prostate cancer among Afro-Caribbeans: The Tobago Prostate Cancer Survey. Cancer Epidemiol Biomarkers Prev. 2002, 11: 726-729.

Brawn PN, Johnson EH, Kuhl DL: Stage at Presentation and survival of white and black patients with prostate carcinoma. Cancer. 1993, 71: 2569-2573. 10.1002/1097-0142(19930415)71:8<2569::AID-CNCR2820710822>3.0.CO;2-R.

Hoffman RM, Gilliland FD, Eley JW: Racial and ethnic differences in advanced-stage prostate cancer: The prostate cancer outcomes study. J Natl cancer Inst. 2001, 93 (5): 388-95. 10.1093/jnci/93.5.388.

French DB, Jones LA: Minority Issues in Prostate Disease. Med Clin N Am. 2005, 89: 805-816. 10.1016/j.mcna.2005.02.003.

Dutta Roy S, Philip J, Javle P: Trends in prostate cancer incidence and survival in various socioeconomic classes: A population-based study. Int J Urol. 2005, 12 (7): 644-53. 10.1111/j.1442-2042.2005.01111.x.

Wilson SS, Crawford ED: Screening for Prostate Cancer: Current Recommendations. Urol Clin North Am. 2003, 31: 219-226. 10.1016/j.ucl.2004.01.002.

Prostate Cancer Epidemiology. [ http://www.cancerline.com/cancerlinehcp/9898_12031_6_1_1.aspx ]

Cooperberg MR, Moul JW, Carrol PR: Changing Face of Prostate cancer. J Clin Oncol. 2005, 23 (32): 8146-8151. 10.1200/JCO.2005.02.9751.

Jemal A, Murray T, Samuels A: Cancer Statistics, 2003. CA Cancer J Clin. 53: 5-26. 10.3322/canjclin.53.1.5.

Holmberg L, Bill-Alexson A, Helgesen F: A Randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med. 2002, 347: 781-789. 10.1056/NEJMoa012794.

Labrie F, Candas B, Cusan L: Screening decreases prostate cancer mortality: 11 year follow-up of the 1988 Quebec prospective randomized controlled trial. Prostate. 2004, 59: 311-318. 10.1002/pros.20017.

Bartsch G, Horninger W, Knlocker H: Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal republic of Tyrol, Austria. Urology. 2001, 58: 417-424. 10.1016/S0090-4295(01)01264-X.

Roberts R, Mathan B: Real Men die from Prostate Cancer. "3rd Annual African American Prostate Cancer Disparity Summit." 2007 Washington DC.